ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 169 filers reported holding ANIKA THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.40 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,138,256 | -68.5% | 61,098 | -56.1% | 0.00% | -100.0% |
| Q2 2023 | $3,613,350 | -13.1% | 139,082 | -4.0% | 0.00% | 0.0% |
| Q1 2023 | $4,159,231 | -4.3% | 144,820 | -1.4% | 0.00% | 0.0% |
| Q4 2022 | $4,345,901 | +21.3% | 146,821 | -2.4% | 0.00% | 0.0% |
| Q3 2022 | $3,582,000 | +16.3% | 150,481 | +9.1% | 0.00% | 0.0% |
| Q2 2022 | $3,079,000 | -7.9% | 137,950 | +3.6% | 0.00% | 0.0% |
| Q1 2022 | $3,342,000 | -29.5% | 133,103 | +0.6% | 0.00% | 0.0% |
| Q4 2021 | $4,738,000 | -20.1% | 132,259 | -5.1% | 0.00% | 0.0% |
| Q3 2021 | $5,931,000 | -4.0% | 139,386 | -2.4% | 0.00% | 0.0% |
| Q2 2021 | $6,180,000 | -4.0% | 142,752 | -9.5% | 0.00% | 0.0% |
| Q1 2021 | $6,438,000 | -10.6% | 157,809 | -0.9% | 0.00% | -50.0% |
| Q4 2020 | $7,205,000 | +22.9% | 159,197 | -3.9% | 0.00% | +100.0% |
| Q3 2020 | $5,861,000 | -24.0% | 165,600 | -19.0% | 0.00% | -50.0% |
| Q2 2020 | $7,716,000 | +27.6% | 204,502 | -2.2% | 0.00% | 0.0% |
| Q1 2020 | $6,046,000 | -47.9% | 209,129 | -6.6% | 0.00% | -33.3% |
| Q4 2019 | $11,610,000 | -10.0% | 223,931 | -4.7% | 0.00% | -25.0% |
| Q3 2019 | $12,900,000 | +24.3% | 235,026 | -8.0% | 0.00% | +33.3% |
| Q2 2019 | $10,379,000 | +32.7% | 255,502 | -1.3% | 0.00% | +50.0% |
| Q1 2019 | $7,824,000 | -9.9% | 258,738 | +0.1% | 0.00% | -33.3% |
| Q4 2018 | $8,688,000 | -27.7% | 258,494 | -9.2% | 0.00% | 0.0% |
| Q3 2018 | $12,010,000 | -25.3% | 284,765 | -43.4% | 0.00% | -25.0% |
| Q2 2018 | $16,086,000 | -38.5% | 502,703 | -4.5% | 0.00% | -42.9% |
| Q1 2018 | $26,171,000 | -8.0% | 526,369 | -0.2% | 0.01% | 0.0% |
| Q4 2017 | $28,432,000 | -9.5% | 527,386 | -2.6% | 0.01% | -22.2% |
| Q3 2017 | $31,400,000 | +29.8% | 541,382 | +10.4% | 0.01% | +28.6% |
| Q2 2017 | $24,199,000 | +100.8% | 490,433 | +76.8% | 0.01% | +133.3% |
| Q1 2017 | $12,049,000 | -4.6% | 277,378 | +7.5% | 0.00% | -25.0% |
| Q4 2016 | $12,628,000 | +29.4% | 257,921 | +26.4% | 0.00% | +33.3% |
| Q3 2016 | $9,760,000 | -11.3% | 203,999 | -0.5% | 0.00% | 0.0% |
| Q2 2016 | $11,003,000 | +4.7% | 205,096 | -12.8% | 0.00% | 0.0% |
| Q1 2016 | $10,514,000 | +13.4% | 235,084 | -3.3% | 0.00% | 0.0% |
| Q4 2015 | $9,275,000 | +2.9% | 243,046 | -14.2% | 0.00% | 0.0% |
| Q3 2015 | $9,016,000 | -1.1% | 283,257 | +2.7% | 0.00% | 0.0% |
| Q2 2015 | $9,114,000 | -17.1% | 275,925 | +3.3% | 0.00% | 0.0% |
| Q1 2015 | $10,996,000 | +10.3% | 267,096 | +9.2% | 0.00% | 0.0% |
| Q4 2014 | $9,967,000 | +15.3% | 244,667 | +3.7% | 0.00% | +50.0% |
| Q3 2014 | $8,646,000 | -54.8% | 235,858 | -42.9% | 0.00% | -33.3% |
| Q2 2014 | $19,120,000 | +161.0% | 412,732 | +131.6% | 0.00% | +50.0% |
| Q1 2014 | $7,325,000 | +37.9% | 178,203 | +28.0% | 0.00% | +100.0% |
| Q4 2013 | $5,311,000 | +27.9% | 139,179 | -20.0% | 0.00% | 0.0% |
| Q3 2013 | $4,154,000 | +181.8% | 173,960 | +100.6% | 0.00% | – |
| Q2 2013 | $1,474,000 | – | 86,706 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Caligan Partners LP | 591,675 | $17,513,580 | 14.58% |
| Trigran Investments, Inc. | 1,564,541 | $46,310,413 | 4.64% |
| DIKER MANAGEMENT LLC | 22,458 | $664,757 | 0.77% |
| Virtus Fund Advisers, LLC | 3,490 | $103,304 | 0.74% |
| Portolan Capital Management | 207,900 | $6,153,840 | 0.61% |
| Virtus Investment Advisers, Inc. | 16,086 | $476,146 | 0.32% |
| Ranger Investment Management | 140,205 | $4,150,068 | 0.31% |
| BOOTHBAY FUND MANAGEMENT, LLC | 367,510 | $10,878,296 | 0.25% |
| Riverwater Partners LLC | 9,778 | $289,429 | 0.25% |
| Legato Capital Management LLC | 7,556 | $223,658 | 0.04% |